Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer (Breast Cancer Res Treat, (2016), 158, 361–371, 10.1007/s10549-016-3878-9)

Mette S. van Ramshorst, Margriet van der Heiden-van der Loo, Gwen M H E Dackus, Sabine C. Linn, Gabe S. Sonke*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

In the original publication of the article, the P-value for two interactions tests was accidently swapped. Under the heading Overall survival, the sentence starting with “Also, for HR status no…… 0 .95)” should read as “Also, for HR status no heterogeneity of treatment effect wasfound (P-value for interaction 0.75). Under the heading Breast cancer-specific survival, the sentence starting with “Again, no evidence…… 0.75)” should read as “Again, no evidence for heterogeneity of treatment effect was found with tumor size (P-value for interaction 0.95). In Table 1 of the Electronic Supplementary Material the hazard ratio for incidence year in the multivariate analysis was placed incorrectly by mistake. The corrected version of the table is given in supplementary material. The conclusion remains unaffected by these corrections.

Original languageEnglish
Pages (from-to)393
Number of pages1
JournalBreast Cancer Research and Treatment
Volume159
Issue number2
DOIs
Publication statusPublished - Sept 2016

Fingerprint

Dive into the research topics of 'Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer (Breast Cancer Res Treat, (2016), 158, 361–371, 10.1007/s10549-016-3878-9)'. Together they form a unique fingerprint.

Cite this